Navigation Links
Single Drug to Check Both Glucose and Cholesterol in Diabetics on the Cards

Tulane University researchers say that a single drug for keeping both glucose and cholesterol levels of patients with type 2 diabetes under check may soon be available.

Lead researcher Dr. Vivian A. Fonseca, Professor of Medicine and Pharmacology at Tulane University School of Medicine, says that the compound colesevelam HCl, in combination with Sulfonylurea-based therapy has been found to significantly reduce glucose levels in patients with type 2 diabetes.

People with uncontrolled type 2 diabetes and high cholesterol face a number of challenges in keeping their glucose levels and cholesterol in check. This study demonstrated the potential to improve two important metabolic parameters with one drug, Fonseca said, while presenting his teams findings at the American Association of Clinical Endocrinologists 16th Annual Meeting and Clinical Congress.

The researchers conducted a clinical trial, dividing patients into two groupsexperimental group (receiving colesevelam HCl), and control group (receiving placebo).

It was found that patients in the experimental group had had significant reductions in blood sugar levels, besides registering a substantial improvement in their lipid profiles over their counterparts in the control group.

The US Food and Drug Administration is currently assessing an application for the commercial production and sale of the drug.

As per the recommendations of the American Diabetes Association, patients with type 2 diabetes should control their glucose levels, and keep their blood sugar level at less than seven per cent.

The National Cholesterol Education Program recommends that such patients keep their cholesterol levels in check, and target a goal of less than 100 mg/dL for bad cholesterol levels in the blood.


'"/>




Page: 1

Related medicine news :

1. Single gene analysis for diagnosis of a range of blood disorders
2. Single drug for bipolar disorder
3. Treating Testicular Cancer With A Single Dose Of Chemotherapy
4. Decreasing Multiple Births By Single Embryo Transfers
5. Single gene skin cancer cause
6. Drug Firms To Produce Single Pill AIDS Treatment
7. Malaria May Gain Resistance To Single Drug Prescriptions
8. Single Women with Baby Cravings Can Actually Cradle their Own, Courtesy NHS
9. Thai Doctors Removed 421 Kidney Stones From A Single Person
10. Single Dose Of Azithromycin Could Cure Trichiasis
11. Effects Of Certain Food Related To Single Pain Receptors
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... ... April 24, 2017 , ... MAP Health Management ... levels in people with addiction who are served by MAP’s patient engagement ecosystem. ... device that monitors heart and breath rates to identify anxiety levels and can ...
(Date:4/24/2017)... ... ... Come to PAINWeekEnd (PWE) Tampa on May 20 and 21, at the ... 2-day program. , An attendee at a recent PAINWeekEnd said, "Very helpful, wish ... course entitled Ain't Misbehavin': Decreasing and Managing Pain Patient Aberrant Behavior, presented by Dr. ...
(Date:4/24/2017)... ... April 24, 2017 , ... “Reflections of God’s Work”: an ... of God’s Work” is the creation of published author, Jerri Broglin, a survivor of ... , “I believe this a great eye-opener for those searching for answers, as we ...
(Date:4/24/2017)... ... ... Life of Purpose Treatment is proud to present “An Evening for Collegiate Recovery ... on May 10th at the University Auditorium. , This benefit concert, featuring Dr. Cheryl ... Collegiate Recovery Community (UFCRC). The concert will kick off the 5th Annual Southeastern CRC ...
(Date:4/23/2017)... ... April 23, 2017 , ... "An event Horizon is a place where the ... my Art and Music. These are created as Metaphysical Transformations where music, which is ... culminate to the ultimate singularity.", -- Karen Salicath Jamali , Karen will also preview ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
(Date:4/18/2017)... Cogentix Medical, Inc. (NASDAQ: CGNT), a global ... and Gynecology markets with innovative and proprietary products, will ... 31, 2017 after the market close on Tuesday, May ... a conference call and webcast to discuss its financial ... at 4:30 p.m. Eastern Time (3:30 p.m. Central Time). ...
(Date:4/18/2017)...  Astute Medical, Inc., developer of biomarkers for better ... at the 2017 National Kidney Foundation (NKF) Spring ... April 22. Physicians will present data on two biomarkers, ... for acute kidney injury (AKI) during the management of ... Elevated levels of TIMP-2 and IGFBP-7 have been ...
Breaking Medicine Technology: